The emergence of synthetic biology is poised to revolutionise healthcare, unlocking new possibilities for regenerative medicine, tissue repair, and personalised treatments. What are the key advancements reshaping this field, and how can businesses harness its potential?

In this episode, we’re joined by Miles Upton, Regional General Manager for Asia at CapGemini, as he shares insights on the promise of synthetic biology, discussing groundbreaking applications such as skin grafts, cartilage repair, and gene therapy. We’ll also examine ongoing research in Asia, highlighting ethical considerations, regulatory frameworks, and the challenges of accessibility.

Join us as we uncover how synthetic biology could redefine healthcare and the broader implications for society and industry.